GET DAILY SIGNALSForesight Autonomous Holdings (FRSX) Declines -39% Over 30 Days on Delisting and Strategic Shifts
Key Takeaways
- Foresight Autonomous Holdings (FRSX) declined roughly 39% over the last 30 days, sliding from about $1.07 to near $0.65.
- The drop extended a longer selloff, with the stock down approximately 50% over the past quarter.
- The company's announced voluntary delisting from the Tel Aviv Stock Exchange and related share-conversion mechanics weighed on sentiment.
- A non-binding plan to acquire a majority stake in a Polish data-center developer raised questions about strategic focus and dilution.
- The two-stage share exchange with VisionWave Holdings implies substantial new-share issuance and a comparatively low post-investment valuation.
- Second-quarter 2026 results showed lower revenue and a widened net loss, reinforcing fundamental pressure on the micro-cap name.
Company Overview and Market Position
Foresight Autonomous Holdings Ltd. is an Israeli technology company headquartered in Ness Ziona that develops advanced three-dimensional (3D) perception systems and cellular-based applications. Through its subsidiaries Foresight Automotive, Foresight Changzhou Automotive, and Eye-Net Mobile, the company offers both "in-line-of-sight" vision systems and "beyond-line-of-sight" accident-prevention solutions. Its flagship QuadSight platform is a four-camera multi-spectral vision solution combining stereoscopic infrared and visible-light cameras, while Eye-Net Mobile provides vehicle-to-everything (V2X) collision-prevention technology delivered through smartphones and other connected devices. These solutions target automotive, defense, autonomous driving, agriculture, heavy industrial equipment, and unmanned aerial vehicle markets. Investors follow FRSX for its exposure to AI-based perception, autonomous mobility, and defense-security themes, though the company remains pre-profit and generates only modest commercial revenue. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, FRSX fell from a closing price of $1.07 on October 5, 2026, to approximately $0.65 in early November, a decline of roughly 39%. The move was not a single-day event but a steady grind lower punctuated by elevated-volume sessions, including a spike of more than four million shares traded on October 13, 2026. The stock's 30-day decline aligns with broader third-party readings showing a roughly 39% drop over the trailing four weeks.
The last quarter tells a similar but steeper story. From about $1.31 in early August, shares fell to near $0.65, representing a decline of approximately 50%. Throughout the period, FRSX traded below both its 50-day and 200-day moving averages, reflecting sustained technical weakness and a persistent downtrend rather than an isolated correction.
What Drove the 30-Day Decline
Several verified developments shaped the 30-day decline. On September 30, 2026, Foresight announced a voluntary delisting of its ordinary shares from the Tel Aviv Stock Exchange (TASE), with the final trading day set for January 1, 2027. A follow-up reminder issued on November 2 encouraged holders to convert ordinary shares into Nasdaq-traded American Depositary Shares, a transition that introduced uncertainty and conversion-related selling pressure.
Days earlier, on September 28, the company entered a non-binding term sheet to acquire a 50.01% controlling interest in a developer of data-center projects in Poland with planned capacity of up to 270 megawatts. The proposed transaction, which included a related-party element because the company's CFO holds a stake in the target, prompted investor questions about a strategic pivot away from its core perception business. Separately, the terms of the previously announced VisionWave Holdings transaction—an exchange that would issue VisionWave roughly 46% of Foresight's shares—continued to weigh on the share count and valuation outlook. Combined with second-quarter results that showed quarterly revenue of $86,000 and a GAAP net loss of about $2.8 million, these factors reinforced a risk-off stance toward the thinly traded micro-cap. From what I see, the combination of these events created sustained pressure.
Drivers Behind the Quarterly Performance
The quarterly decline reflects a longer-running repricing. In June 2026, Foresight executed a definitive agreement under which VisionWave Holdings (VWAV) would acquire up to 52% of Foresight through a staged share exchange valued at about $17.5 million in VisionWave stock, implying a post-investment valuation near $34 million. The transaction contemplates issuing newly created ordinary shares representing 46% of the company at the Stage 1 closing, a meaningful dilution signal for existing holders. Earlier in the year, Foresight also completed a one-for-three reverse split and ADS ratio change effective February 26, 2026, to help maintain Nasdaq listing compliance. Together with weak financial results and a rotation away from speculative AI-mobility names, these structural and dilution-related developments drove the stock's multi-month decline.
Key Factors Investors Should Watch Next
Looking ahead, investors should monitor several key factors. The completion of the VisionWave Stage 1 exchange remains subject to regulatory approvals, Nasdaq listing requirements, and other closing conditions, and its outcome will directly affect share count and control. The TASE delisting is scheduled to conclude on January 4, 2027, with a January 7, 2027 deadline for fee-free conversions to ADSs. The proposed Polish data-center acquisition remains non-binding and depends on due diligence, an independent valuation, and definitive documentation. Additionally, upcoming quarterly results, progress on commercialization agreements and proof-of-concept programs such as the Zeda Korea road-safety initiative, and any updates on Eye-Net's V2X deployments will help determine whether the company can stabilize revenue and sentiment. As with any micro-cap development-stage company, dilution risk, cash-burn, and execution uncertainty remain central considerations. I’m watching this closely for any updates on closing conditions.
Exploring AI-Driven Trading Approaches
In my own research process, I sometimes review Tickeron’s Trending AI Robots to compare systematic strategies against manual analysis. This page highlights a curated selection of AI trading bots that monitor thousands of tickers, focusing on top-performing ones across different styles, timeframes, and risk profiles. It provides a practical way to evaluate algorithmic options alongside fundamental work without replacing individual due diligence.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
FRSX's Stochastic Oscillator remains in oversold zone for 7 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
Following a +3.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where FRSX advanced for three days, in 148 of 193 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
FRSX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FRSX as a result. In 75 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for FRSX turned negative on October 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 42 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FRSX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for FRSX entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.376) is normal, around the industry mean (0.773). P/E Ratio (-0.095) is within average values for comparable stocks, (40.481). Projected Growth (PEG Ratio) (0.620) is also within normal values, averaging (1.494). Dividend Yield (0.046) settles around the average of (0.042) among similar stocks. P/S Ratio (9.643) is also within normal values, averaging (49.456).
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. FRSX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FRSX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of residential and commercial real estate properties
Industry AutoPartsOEM
Advertisement